These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 14645198)

  • 1. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
    Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
    Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
    Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
    Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
    Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
    Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interaction between parkin and PINK1 in mammalian neuronal cells.
    Um JW; Stichel-Gunkel C; Lübbert H; Lee G; Chung KC
    Mol Cell Neurosci; 2009 Apr; 40(4):421-32. PubMed ID: 19167501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
    Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A
    Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lewy-body formation is an aggresome-related process: a hypothesis.
    Olanow CW; Perl DP; DeMartino GN; McNaught KS
    Lancet Neurol; 2004 Aug; 3(8):496-503. PubMed ID: 15261611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant-negative effect of mutant valosin-containing protein in aggresome formation.
    Kitami MI; Kitami T; Nagahama M; Tagaya M; Hori S; Kakizuka A; Mizuno Y; Hattori N
    FEBS Lett; 2006 Jan; 580(2):474-8. PubMed ID: 16386250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
    Jiang H; Ren Y; Zhao J; Feng J
    Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin is linked to the ubiquitin pathway.
    Tanaka K; Suzuki T; Chiba T; Shimura H; Hattori N; Mizuno Y
    J Mol Med (Berl); 2001 Sep; 79(9):482-94. PubMed ID: 11692161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin and defective ubiquitination in Parkinson's disease.
    Dawson TM
    J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.
    Um JW; Park HJ; Song J; Jeon I; Lee G; Lee PH; Chung KC
    Biochem Biophys Res Commun; 2010 Mar; 393(4):824-8. PubMed ID: 20171192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective.
    Tanaka M; Kim YM; Lee G; Junn E; Iwatsubo T; Mouradian MM
    J Biol Chem; 2004 Feb; 279(6):4625-31. PubMed ID: 14627698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
    Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkin accumulation in aggresomes due to proteasome impairment.
    Junn E; Lee SS; Suhr UT; Mouradian MM
    J Biol Chem; 2002 Dec; 277(49):47870-7. PubMed ID: 12364339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
    Wang C; Ko HS; Thomas B; Tsang F; Chew KC; Tay SP; Ho MW; Lim TM; Soong TW; Pletnikova O; Troncoso J; Dawson VL; Dawson TM; Lim KL
    Hum Mol Genet; 2005 Dec; 14(24):3885-97. PubMed ID: 16278233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin-associated Parkinson's disease.
    von Coelln R; Dawson VL; Dawson TM
    Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes.
    Marambio P; Toro B; Sanhueza C; Troncoso R; Parra V; Verdejo H; García L; Quiroga C; Munafo D; Díaz-Elizondo J; Bravo R; González MJ; Diaz-Araya G; Pedrozo Z; Chiong M; Colombo MI; Lavandero S
    Biochim Biophys Acta; 2010 Jun; 1802(6):509-18. PubMed ID: 20176105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
    Hattori N; Machida Y; Noda K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.